ABEOW - Abeona Therapeutics Inc Warrants 2015-19.12.19 on Shs
Previous close
0.0699
0 0%
Share volume: 0
Last Updated: Fri 20 Dec 2019 06:00:00 AM CET
Pharmaceuticals: Generic:
0.65%
PREVIOUS CLOSE
CHG
CHG%
$0.07
0.00
0.00%
Summary score
0%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
0%
Sector
Health Technology
Industry
Pharmaceuticals: Generic
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over timeo
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over timeo
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ABEOW | AGN | MYL | PETX |
|---|---|---|---|---|
| Return on equity | 0% | -0.34% | 0.77% | -10.54% |
| Return on assets | 0% | 0.09% | 0.92% | -5.69% |
| Return on sales | 0% | 1.71% | 10.44% | -3529.01% |
| Return on invested capital | 0% | -0.1% | 0.42% | -43.38% |
| Profitability | 0% | 7% | 100% | 0% |
| Total debt ratio | 0% | 37.49% | 63.68% | 28.72% |
| Debt ratio change over time | 0% | -131.92% | 92.73% | -1.64% |
| Dept financing | 0% | 15% | 50% | 11% |
| Current Ratio | 0% | 1% | 1.19% | 0% |
| Quick Ratio | 0% | 0.88% | 0.7% | 0% |
| Cash Position Ratio | 0% | 0.16% | 0.07% | 0% |
| Liquididy | 0% | 18% | 14% | 75% |
| Short-term ratios | ABEOW | AGN | MYL | PETX |
|---|---|---|---|---|
| Return on equity | 0% | -0.41% | 0.72% | 0% |
| Return on assets | 0% | 0.24% | 0.93% | 0% |
| Return on sales | 0% | 5.3% | 9.55% | 0% |
| Return on invested capital | 0% | -0.32% | 0.43% | 0% |
| Profitability | 0% | 20% | 100% | 0% |
| Total debt ratio | 0% | 37.01% | 62.04% | 0% |
| Debt ratio change over time | 0% | -45.17% | 182.21% | 0% |
| Dept financing | 0% | 15% | 50% | 0% |
| Current Ratio | 0% | 1% | 1.19% | 0% |
| Quick Ratio | 0% | 0.88% | 0.7% | 0% |
| Cash Position Ratio | 0% | 0.16% | 0.07% | 0% |
| Liquididy | 0% | 71% | 56% | 0% |